A study evaluating a pioneering lentivirus (LV)-mediated gene therapy trial for classical Fabry disease showed promising ...

There was a lot of excitement when Tepezza became the first drug approved for the treatment of thyroid eye disease in January ...

A 64-year-old woman presented to an outside provider with 5 days of left eye “burning, itching, redness and blurry vision” ...

Dry eyes affect millions of people each year, and research suggests the condition is on the rise. Yet, like Rotenberg, many ...

Spain's SpliceBio has raised $135m in financing that will help it move a gene-editing therapy for Stargardt disease through clinical testing.